Pharaoh’s CSF management system secures FDA breakthrough designation
Pharaoh’s Neurapheresis is under development to advance existing treatment options to patients following aneurysmal subarachnoid haemorrhage (aSAH).
Pharaoh’s Neurapheresis is under development to advance existing treatment options to patients following aneurysmal subarachnoid haemorrhage (aSAH).
The British government will now change up AI-enabled medical device regulation to encourage innovation with the appropriate guardrails.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Drug delivery’s next bottleneck isn’t innovation, it’s industrial capacity
Australia starts investigation into OpenAI Medicare breach
Industry partnership will determine the success of the transition to low-GWP pMDIs
UK government champions healthtech through new NHS access programme